Skip to main content

Tags

cell culture

downstream processing

upstream processing

JSR Corporation and KBI Biopharma, Inc. Agree to Acquisition; INCJ and CMIC of Japan also participate
​Exploring Options for Dual Sourcing of Single-Use Components - BioProcess International, Dec 2014

​Exploring Options for Dual Sourcing of Single-Use Components - BioProcess International, Dec 2014

News   •   Jan 15, 2015 08:40 GMT

One of the hottest topics that came out the research for this year's BioProcess International Europe conference was single-use systems, and in particular, dual sourcing. ------------------------------------------

Increasing Capacity Utilization in Protein A Chromatography - Biopharm International

Increasing Capacity Utilization in Protein A Chromatography - Biopharm International

News   •   Jan 06, 2014 08:54 GMT

An mAb purification study tests a twin-column capture process

Elucidating Biosimilars Characterization

Elucidating Biosimilars Characterization

News   •   Dec 19, 2013 07:48 GMT

Industry experts discuss the importance of characterization studies during biosimilars development and related analytical methods.

Comparing Protein A Resins for Monoclonal Antibody Purification

Comparing Protein A Resins for Monoclonal Antibody Purification

News   •   Dec 17, 2013 14:47 GMT

Comparing Protein A Resins for Monoclonal Antibody PurificationA prototype Protein A resin is evaluated for purification performance, reusability, and cost performance.

German biotech sector remains positive although expectations are lower than before

German biotech sector remains positive although expectations are lower than before

News   •   Mar 13, 2013 08:13 GMT

Despite having lower expectations for the future, the biotechnology sector regards its current situation as better than last year.

BPI Europe Inspirational Speaker - Marc Koska: 1.3m reasons to re-invent the syringe

BPI Europe Inspirational Speaker - Marc Koska: 1.3m reasons to re-invent the syringe

News   •   Mar 08, 2013 11:56 GMT

Hear Marc's amazing story at next month's BioProcess International Europe conference ----- Reuse of syringes, all too common in under-funded clinics, kills 1.3 million each year. Marc Koska clues us in to this devastating global problem with facts, photos and hidden-camera footage. He shares his solution: a low-cost syringe that can't be used twice.

Latest BPI Attendee List Update

Latest BPI Attendee List Update

News   •   Mar 07, 2013 19:00 GMT

With over 6 weeks left until the event here is the latest list of companies due to attend the BPI European conference on the 17th & 18th of April in Dusseldorf.

BPI Europe 2013 - Latest Conference Update

BPI Europe 2013 - Latest Conference Update

News   •   Feb 11, 2013 16:12 GMT

After announcing the 2013 programm in October 2012, the latest conference is on track to being the biggest BPI event in Europe to date. Here is a brief summary of what is in store...

Scientific Publication of The Week - The intriguing options of multispecific antibody formats for treatment of cancer

Scientific Publication of The Week - The intriguing options of multispecific antibody formats for treatment of cancer

News   •   Feb 08, 2013 10:37 GMT

The advent of various technologies for the generation of bi- and multispecific recombinant antibody-based molecules brought with it a multitude of formats for selecting target combinations. Some of the format options are outlined from a technical point of view.

Improvements in Research and Manufacturing will Help Offset $1bn cost cutting, says GSK

Improvements in Research and Manufacturing will Help Offset $1bn cost cutting, says GSK

News   •   Feb 07, 2013 15:24 GMT

GlaxoSmithKline ($GSK) aims to chop £1 billion ($1.57 billion) in annual spending in Europe, R&D and manufacturing by 2016 through technical improvements in research and manufacturing, but GSK CEO Andrew Witty expects job cuts to be part of the European cost savings.

Pfizer Will Evaluate Whether to Divide Drug Units, CEO Read Says Drew Armstrong - ©2013 Bloomberg News

Pfizer Will Evaluate Whether to Divide Drug Units, CEO Read Says Drew Armstrong - ©2013 Bloomberg News

News   •   Feb 05, 2013 09:00 GMT

Jan. 30 (Bloomberg) -- Pfizer Inc., the world’s largest drugmaker, may consider dividing its branded medicines and generic products units into separate businesses, Chief Executive Officer Ian Read said.

Lonza pins future hopes on ADC manufacturing

Lonza pins future hopes on ADC manufacturing

News   •   Feb 04, 2013 17:23 GMT

ZURICH, Jan 24 (Reuters) - Swiss specialty chemicals and life sciences group Lonza reported a better than expected rise in profits on Thursday but dampened expectations of another big jump this year, taking the edge off a two-month rally in the share price.

Sartorius Profits Jump 20% driven by growth in bioprocessing

Sartorius Profits Jump 20% driven by growth in bioprocessing

News   •   Jan 31, 2013 08:00 GMT

Sartorius said today it finished last year with a 20% jump in profits, helped by growing U.S. revenue as well as growth in its bioprocessing, industrial weighing, and lab products and services units.

Sanofi’s Chief Says Investors Underestimate Drug Pipeline - Originally Published in Bloomberg

Sanofi’s Chief Says Investors Underestimate Drug Pipeline - Originally Published in Bloomberg

News   •   Jan 29, 2013 15:48 GMT

Sanofi (SAN) Chief Executive Officer Chris Viehbacher says investors are still underestimating the French company’s pipeline of experimental drugs.